Two domains, one of which did not answer
We went looking for QSC’s storefront and found an information site instead. The company, which also trades as Qingdao Sigma Chemical, runs a cluster of Western-facing domains. The information site, qscpeptidelab.com, loaded during our check on 2026-10-19 and is the source of every claim we test below. The order domain it points to, qscpeptide.com, failed DNS resolution at fetch time, and a third domain, qsc-usa.com, redirected to the one that would not resolve. That means no storefront price, including the BPC-157 price we record for every supplier, could be verified, and the budget price tier in our record rests on third-party description rather than on anything we saw.
What we could read is a Chinese bulk and direct supplier with a catalog of more than 75 vials and bulk listings, heavy on GLP-class products and rounded out with BPC-157, TB-500, CJC-1295, Ipamorelin and GHK-Cu. A third-party wiki dates the company to 2008 and places it in Qingdao, Shandong; the company’s own pages give neither a founding year nor a street address. With the storefront dark, we tested the information site’s statements against the one deep independent source available, the 26-page vendor report published by Finnrick, an independent testing aggregator, along with PeptideProtocolWiki and a review site.
The claims, and the part of them that held up
The information site claims purity of 99 percent or better by HPLC across the catalog, certificates issued by Janoshik Analytical Laboratories that anyone can verify by batch identifier on Janoshik’s own site, testing by both HPLC and mass spectrometry, domestic shipping from warehouses in eight regions covering the US, EU, UK, Canada, Australia, Singapore, Thailand and Vietnam, and payment in crypto. A research-use-only disclaimer appears on the site. No GMP or ISO certification is claimed, so none can be overstated, and no returns policy or guarantee is published anywhere we could find.
The laboratory claim is the strongest thing QSC has, and in principle it is checkable. Janoshik publishes verification records, so a batch identifier printed on a certificate can be tested against the laboratory’s database by anyone, including a buyer holding a vial. The methods described are the standard pair for identity and purity. The product count and the shape of the catalog are consistent between the information site and Finnrick’s listing, which is a small sign that the information site describes the same business Finnrick tested. Finnrick’s results on one GLP-class product were comparatively strong, an 83 percent rating across 18 tests, and we report that alongside the weaker numbers rather than leaving it out.
What did not hold up, and what we could not verify
The certificate claim breaks down at the point where paper meets vial. Finnrick reports forum records of 2024-dated certificates being used for 2025 product, and of vials arriving unlabeled or without a batch number. A verifiable Janoshik certificate proves little if nothing on the vial ties it to that certificate. Finnrick’s own program records 50 tests on QSC products with 33 passes and 17 failures, a 61 percent rating, and puts BPC-157 at 51 percent across 4 tests. We did not run those tests and we present the figures as Finnrick states them.
The ordering story contradicts itself. Finnrick’s report cites a Telegram source stating that QSC has no websites at all, while qscpeptide.com and qsc-usa.com claim that ordering is website-only. Finnrick also documents lookalike domains at qingdaosigmachemical.com and .net, customs-declaration mismatches, and shipments labeled “Honeysuckle Oil” in transit. For a buyer, each of those is a way to lose an order with no payment-side recourse, because checkout is BTC or USDT on the storefront and, per a third-party listing, bank wire as the only alternative.
The catalog is not limited to peptides. Finnrick and PeptideProtocolWiki both list controlled substances among QSC’s offerings, which is a material business-practice fact for any buyer in a jurisdiction that regulates them, and which places the company outside the peptide-only suppliers it is often compared with. Both sources also report that QSC was permanently banned from the MESO-Rx forum for doxxing a customer who complained. We have no way to independently confirm the ban, and we note that two separate sources report it. How a company responds to a complaint is part of its business practice, and this is the only account of that practice in the record.
The list of what we could not verify is long. No storefront price. Whether certificates are public and issued per lot. Endotoxin and sterility testing, which the information site does not mention. Shipping carriers and turnaround. Returns and guarantees, for which the record holds nothing at all. The founding year and the Qingdao location come from PeptideProtocolWiki, not from the company. A phone number exists only as two WhatsApp contacts per Finnrick, and an address at 40 Shandong Road appears only on seekpeptides.com, unverified. No Trustpilot page exists, no FDA warning letter naming Qingdao Sigma Chemical was found as of 2026-10-19, and Reddit presence is recorded as some.
Our read
QSC is the kind of supplier whose price advantage, which we are told about but did not see, comes bundled with every risk this market can produce: crypto-only payment, no fixed storefront, lookalike domains, stale certificates on unlabeled vials, a mixed catalog that includes controlled substances, and a documented account of retaliation against a complaint. The Janoshik relationship appears to be real and the verification mechanism exists. What Finnrick’s report leaves open is whether a given vial matches a given certificate, and a buyer should assume that question has to be answered by their own test, at their own cost, after paying in a currency that cannot be clawed back. For a lab that needs documented identity and purity before material enters its own work, that is the wrong order of operations.
